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Background: Elevated concentrations of plasma glucose appear to play a role in memory impairment, and it has
been suggested that insulin might also have a negative effect on cognitive function. Our aim was to study whether
glucose, insulin or insulin resistance are associated with episodic or semantic memory in a non-diabetic and
non-demented population.
Methods: We linked and matched two population-based data sets identifying 291 participants (127 men and 164
women, mean age of 50.7 ± 8.0 years). Episodic and semantic memory functions were tested, and fasting plasma
insulin, fasting plasma glucose, and 2-hour glucose were analysed along with other potential influencing factors on
memory function. Since men and women display different results on memory functions they were analysed
separately. Insulin resistance was calculated using the HOMA-IR method.
Results: A higher fasting plasma glucose concentration was associated with lower episodic memory in women
(r = −0.08, 95% CI −0.14; −0.01), but not in men. Plasma insulin levels and insulin resistance were not associated
with episodic or semantic memory in women or in men after adjustments for age, fasting glucose, 2-hour glucose,
BMI, education, smoking, cardiovascular disease, hypertension, cholesterol, and physical activity.
Conclusions: This indicates that fasting glucose but not insulin, might have impact on episodic memory in
middle-aged women.
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Type 2 diabetes is associated with increased risk for cogni-
tive decline [1] and dementia [2], including Alzheimer’s
disease [3]. The mechanisms behind these associations,
however, are not fully understood. One reason for this as-
sociation could be cardiovascular disease [4] and another
cause might be the effects of metabolic perturbations [1].
High concentrations of glucose appear to play an im-
portant role in cognitive dysfunction [5] and dementia [6],
and previous studies have revealed that cognitive impair-
ments can occur even before the diagnosis of type 2 dia-
betes, i.e., in a pre-diabetic stage [7]. In line with this, we
have previously reported that increased plasma glucose* Correspondence: anna.backestrom@umu.se
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unless otherwise stated.concentrations in non-diabetic women were associated
with impairments in episodic memory [8]. It is well known
that men and women display different results on different
memory functions [9,10]. Thus it is of importance to also
analyse men and women separately.
Before the onset of type 2 diabetes, the concentrations
of insulin in the plasma increase as a result of insulin re-
sistance. Some studies have indicated that elevated insulin
concentrations [11-13] and insulin resistance [12,13] are
associated with an increased risk of Alzheimer’s disease
and impairments in cognitive function [11]. It is still un-
clear, however, whether insulin concentrations or insulin
resistance play a role in memory function in the normo-
glycemic population [14,15].
Insulin influences the central nervous system as a neu-
romodulator [16] and regulates energy metabolism and
neurotransmission [16,17]. Insulin crosses the blood brainntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Flow-chart of the study population.
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[16,18] and insulin receptors are located in the medial
temporal structures that support memory function
[16,17]. Insulin might also affect memory through its in-
hibition of insulin degrading enzyme that in turn leads to
a failure to degrade amyloid-β, a hallmark of Alzheimer’s
disease [19].
To determine the possible associations between glu-
cose, insulin, and development of impaired memory
function, it is useful to study persons before the onset of
diabetes or dementia to minimize the confounding ef-
fects of these diseases. Thus, our aim was to investigate
whether insulin resistance, elevated concentrations of in-
sulin or glucose were associated with impaired episodic




We used data from two population-based surveys. The
Betula Prospective Cohort Study (n = 3,527) investigated
how memory functions and health develop over the
adult life span [20]. The database with the participants
in the Betula study was linked to the database of partici-
pants in the Västerbotten Intervention Program (VIP)
(n = 72,861). The VIP is a health survey to which all in-
habitants in the county of Västerbotten in northern
Sweden have been invited to participate at the ages of
40, 50, and 60 years since 1987 [21].
In the Betula study years of formal education and any
history of cardiovascular events were collected by ques-
tionnaire. Episodic- and semantic memory tests were per-
formed. Episodic memory test included test of face/name
recognition, sentence learning with encoding enactment,
sentence learning without enactment, word recall, learning
of facts, prospective memory, and memory for activities.
Semantic memory included vocabulary, general know-
ledge, and word fluency tests. The procedures of the tests
have been described in detail elsewhere [20,22].
In the VIP study weight and height were measured and
body mass index (BMI; kg/m2) was calculated. Smokers
were defined as those reporting daily smoking or “occa-
sional smoking” and ex-smokers were classified as non-
smokers. Blood pressure was measured with participants
in a supine position after 5 minutes of rest. Hypertension
was defined as self-reported hypertension, the use of anti-
hypertensive medication, or systolic blood pressure
≥140 mmHg and/or diastolic blood pressure ≥90 mmHg.
Fasting plasma glucose and total fasting plasma choles-
terol concentrations were measured in capillary plasma on
a Reflotron bench-top analyser (Boeringer Mannheim
GmbH, Mannheim, Germany) after an overnight fast. An
oral glucose tolerance test was performed to measure 2-
hour plasma glucose (2hPG) after a 75 g glucose load.Fasting plasma insulin was analysed (Roche Cobas
e601 analyser, Roche Diagnostics, Diamond Diagnostics,
Holliston, MA), and the homeostasis model assessment
insulin-resistance (HOMA-IR) was used to calculate insu-
lin resistance [23].
Physical activity was assessed from a questionnaire in
the VIP that asked, “How often have you trained in an ex-
ercise outfit in the last three months in order to improve
your fitness and/or to feel good?” The five response op-
tions were 1) never, 2) occasionally, not regularly, 3) once
weekly, 4) two to three times per week, and 5) more than
three times per week. The answers were categorized into a
low activity group (responses 1 and 2) and a high activity
group (responses 3–5).
A flow-chart of the population is presented in Figure 1.
We identified 1,346 individuals who had participated in
both studies. To limit the risk of changes in metabolic
variables due to the difference in time, we excluded
participants with more than 6 months between surveys.
Participants with fasting plasma glucose (fPG) ≥7.0 mmol/L
or a glucose concentration two hours after glucose adminis-
tration (2hPG) ≥12.2 mmol/L were considered to have dia-
betes and were excluded, as were those who reported
that they had diabetes. We screened for dementia with
the Mini Mental State Examination (MMSE) [24] and a
score below 24 lead to exclusion. Participants filled in a
screening test for depression (Centre for Epidemiologic
Studies Depression Scale; CES-D) [25], and a score
above 15 lead to exclusion, leaving 392 persons. Fasting
plasma insulin concentrations (fPI) were available for 333
of these individuals. One insulin value was excluded as an
error value (754 pmol/L). After correction for missing
values in the variables for the potential influencing factors
of memory it remained 291 participants in the study
population (164 women and 127 men with a mean age of
50.7 ± 8.0 years). Forty-eight participants who lacked infor-
mation on CES-D remained in the study population. To
investigate if there was any signs of selection bias we
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sample of 1346 persons (mean years of education 11.8 (SD
3.9) years; mean weight 74.3 (SD 13.3) kg) and our study
sample (n = 291; mean years of education. 11.5 (SD 3.9)
years; weight 74.0 (SD 12.8) kg; p > 0.05 for both
comparisons).
The participants gave their informed consent, and we
obtained approval from the ethics committee in Umeå,
Sweden.
Statistical analyses
In the statistical analyses descriptive data are presented
as mean values with standard deviations (SD), numbers
(n), and proportions (%). We standardized the memory
testing data using the mean values and SD from the
youngest age group to compute a composite z-score (z
= (score - 40-year-old mean) / 40-year-old SD). Statis-
tical significance of the means and proportions between
the groups was tested for continuous and categorical
variables by Student’s t-tests and chi-square tests, re-
spectively. Pearson’s correlation analyses were per-
formed. A difference was regarded as statistically
significant when p <0.05.
We performed a partial least square regression analysis
(PLS) [26] to examine the independent effects of glu-
cose, insulin, and insulin resistance on episodic and se-
mantic memory with adjustments for age, BMI,
education level, smoking, cardiovascular disease, hyper-
tension, cholesterol, and physical activity. PLS is a multi-
variate method that is used to best estimate the
importance of the potential covariates in the model by
determine how multiple x-variables co-vary with y-
variables. Thus, PLS does not require independence
among measures and is, therefore, able to deal with
multicolinearity better than many other regression
models [27]. Potential influencing factors were chosen
because of their possible association to memory func-
tion based on previous findings. All variables were
scaled to unit variance and centered before being intro-
duced into the model. The jack-knife technique [28]
was used to calculate the standard error and to estimate
the 95% confidence intervals (CI) for the PLS- regres-
sion coefficients (r).
IBM SPSS Statistics 19.0 and the R: A language and
environment for statistical computing [29] was used for
statistical calculation.
Results
Women had higher 2hPG than men, but there were no
differences in fasting glucose or fasting insulin (Table 1).
More men than women had hypertension. Women had
better scores for both episodic and semantic memory
compared to men, and these gender differences in mem-
ory function were explained by better results in theyounger female age groups (Table 1). Due to the differ-
ence between men and women in the dependent vari-
ables, we stratified all of the data for gender.
In the correlation analysis, episodic memory in women
was correlated with exercise and educational level and
inversely correlated with older age, fPG, 2hPG, fPI,
HOMA-IR, previous incidence of cardiovascular disease
(CVD), hypertension and cholesterol (Table 2). Years of
education correlated with episodic memory performance
in men. BMI and cholesterol values were inversely corre-
lated (Table 2).
Semantic memory in women was correlated with exer-
cise and inversely correlated with age, 2hPG, previous
CVD, hypertension and cholesterol. (Table 2). In men
semantic memory was inversely correlated with age and
BMI. Education was correlated with semantic memory
in both women and men (Table 2).
We used two matrix components in the PLS analysis
explaining 29.3% in women and 24.7% in men of the
variance for the dependent variable episodic memory,
and 31.4% in women and 37.3% in men of the variance
for the dependent variable semantic memory. We in-
cluded age, fasting glucose, 2-hour glucose, fasting insu-
lin, HOMA-IR, BMI, education, smoking, cardiovascular
disease, hypertension, cholesterol, and physical activity
as potential influencing factors of memory.
Poorer episodic memory function in women was asso-
ciated with a higher glucose concentration (r = −0.08,
95% CI −0.14; −0.01) and a higher age (Figure 2a). Men
with a higher BMI had lower scores on episodic memory
(r = −0.06, 95% CI −0.13; −0.0005) (Figure 2b) and se-
mantic memory (r = −0.19, 95% CI −0.32; −0.055)
(Figure 3b.). Higher concentrations of glucose in men
were associated with better performance on semantic
memory tests (r = 0.14, 95% CI 0.04; 0.25) (Figure 3b).
Years of education were a predictor for better episodic
and semantic memory scores for both women (Figures 2a
and 3a) and for men (Figures 2b and 3b).
Fasting insulin or HOMA-IR was not associated to
episodic or semantic memory in women or in men in
the PLS regression analysis.
Discussion
Fasting plasma glucose was associated with poorer epi-
sodic memory in women. In contrast, we found no sig-
nificant association between insulin concentrations or
insulin resistance and episodic or semantic memory.
This suggests that elevated glucose concentrations might
influence memory function more, or earlier, than insulin.
A few studies have investigated the association be-
tween glucose, insulin, insulin resistance, and memory
function in non-diabetic middle-aged individuals. When
comparing different studies, it is important to take into
account the effect of age on cognitive function because
Table 1 Characteristics of the study population by gender
Women Men p All
n 164 127 NS 291
Time between surveys (days) 13.9 (68.5) 17.6 (70.2) NS 15.5 (69.1)
Age (years) 51.0 (8.1) 50.3 (8.0) NS 50.7 (8.0)
40 years (n) 46 38 NS 84
50 years (n) 55 47 NS 102
60 years (n) 63 42 NS 105
fP-glucose (mmol/L) 5.2 (0.54) 5.3 (0.56) NS 5.3 (0.55)
2hP-glucose (mmol/L) 6.8 (1.26) 6.4 (1.48) 0.007 6.6 (1.37)
fP-insulin (pmol/L) 54.9 (61.51) 47.6 (24.58) NS 51.7 (49.00)
HOMA-IR 1.03 (1,11) 0.90 (0.47) NS 0.97 (0.89)
Hypertension (%) 27 39 0.023 32
Cholesterol (mmol/L) 5.9 (1.29) 5.9 (1.18) NS 5.9 (1.24)
BMI 25 (4.2) 26 (3.0) NS 26 (3.7)
Educational level (years) 12 (3.8) 12 (3.9) NS 12 (3.9)
Smoking (%) 20 26 NS 23
Cardiovascular disease (%) 27 20 NS 24
Exercise group (high) (%) 35 31 NS 33
Episodic memory (score) 7.29 (1.39) 6.62 (1.30) <0.001 7.00 (1.39)
40 years 7.92 (1.41) 6.69 (1.20) <0.001 7.36 (1.45)
50 years 7.39 (1.25) 6.75 (1.43) 0.019 7.09 (1.36)
60 years 6.75 (1.30) 6.42 (1.25) NS 6.62 (1.29)
Semantic memory (score) 15.96 (2.82) 15.20 (3.03) 0.028 15.6 (2.94)
40 years 16.86 (2.10) 15.56 (2.07) 0.005 16.27 (2.17)
50 years 15.86 (3.07) 15.67 (2.90) NS 15.77 (2.98)
60 years 15.39 (2.93) 14.33 (3.72) NS 14.96 (3.30)
Data are shown as numbers (n), proportions (%), or mean values with the standard deviation in parentheses. P-values are given for differences between genders.
NS means not significant. HOMA-IR is a calculated value for insulin resistance.
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insulin, glucose, and memory [30,31]. We included 40,
50 and 60-year old volunteers in our study, i.e., the mean
age was 50.7 (8.0) years.
The present results are in line with Messier et al. [32]
who showed that higher blood glucose, but not insulin, was
associated with poorer episodic memory in a population of
20-year-old students. Our findings are also corroborated byTable 2 Correlation between episodic and semantic memory
Age fPG 2hPG fPI HOMAIR BMI
Women
Episodic −0.34‡ −0.28‡ −0.24† −0.19* −0.20* −0.11
Semantic −0.21† −0.09 −0.19* −0.08 −0.08 −0.12
Men
Episodic −0.08 0.08 −0.02 −0.14 −0.13 −0.22†
Semantic −0.16* 0.14 −0.001 −0.13 −0.12 −0.29‡
*p <0.05, † p <0.01, ‡ p <0.001.
Episodic and semantic memory, age, fasting plasma glucose (fPG), glucose after 2 hour
BMI, years in formal education, smoking, cardiovascular disease (CVD), hypertension (HSanz et al. [15] who found that neither increased fasting in-
sulin nor insulin resistance were associated with episodic
memory or semantic memory in a study population with a
mean age of 50 years. Our study is in contrast to studies
with older participants. For example, Bruehl et al. [33]
showed that non-diabetic participants, with an average age
of 63 years and with increased insulin resistance, showed
poorer episodic memory. Tan et al. [14] found in theand potential influencing factors by gender
Education Smoking CVD HT Cholesterol Exercise
0.38‡ 0.06 −0.18* −0.22† −0.24† 0.18*
0.55‡ 0.05 −0.22† −0.21† −0.19* 0.16*
0.44‡ −0.06 −0.01 −0.12 −0.22* 0.17
0.59‡ −0.08 −0.07 −0.01 −0.04 0.06
s glucose load (2hPG), fasting plasma insulin (fPI), insulin resistance (HOMA-IR),
T), cholesterol, and physical activity (exercise).
Figure 2 Episodic memory in women and men in a PLS regression analysis. (a) Episodic memory in women. The association between
episodic memory and age, glucose, 2-hour glucose, insulin, insulin resistance (HOMA-IR), BMI, education, smoking, CVD, hypertension, cholesterol,
and exercise group in women. (b) Episodic memory in men. The association between episodic memory and age, glucose, 2-hour glucose, insulin,
insulin resistance (HOMA-IR), BMI, education, smoking, CVD, hypertension, cholesterol, and exercise group in men.
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ing insulin were related to reduced episodic memory
among participants of about 61 years of age who did not
have clinical diabetes. In a study by Kim et al. [34] a signifi-
cant decrease in semantic memory was found in non-
diabetic participants of about 71 years of age, and with mild
cognitive impairments (MCI). However, this was only true
for those who were APOE4 positive. Finally, Benedict et al.
[35] found that insulin resistance was associated with
poorer semantic memory performance in a population of
75 year olds. The discrepancy between our study and the
four latter studies may be due to increased prevalence of
metabolic and structural changes in older age [36].
Older ages in the latter studies are also associated
to more components of the metabolic syndrome i.e.Figure 3 Semantic memory in women and men in a PLS regression a
semantic memory and age, glucose, 2-hour glucose, insulin, insulin resistance
exercise group in women. (b) Semantic memory in men. The association betw
resistance (HOMA-IR), BMI, education, smoking, CVD, hypertension, cholesterohyperglycemia, hyperinsulinemia, obesity, hypertension
and hyperlipidemia. Our sample is relatively young, which
may explain why we have only found an association to
parts of the metabolic syndrome. It is possible that the in-
creased insulin levels and/or insulin resistance could be
more important for other cognitive profiles than those
assessed in our study.
We found a difference in memory function between
men and women. Women generally perform better than
men on episodic memory verbal tasks and non-verbal
tasks, e.g., face recognition [9,10], but there is currently no
established explanation for this gender effect. The gender
differences in episodic memory and semantic memory in
our study were only seen in younger participants, i.e., pre-
menopausal women, which could support the theory of annalysis. (a) Semantic memory in women. The association between
(HOMA-IR), BMI, education, smoking, CVD, hypertension, cholesterol, and
een semantic memory and age, glucose, 2-hour glucose, insulin, insulin
l, and exercise group in men.
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monly regarded as mediators of the gender difference, but
studies have shown conflicting results [10] and the facts
that girls perform better than boys in episodic memory
[37,38] and that the difference seems to be consistent over
the entire life span [9,39] argue against this explanation as
the sole cause for gender differences.
The finding of an association between a higher BMI
and impairment in both episodic and semantic memory
in men is in line with previous studies that have found
that obesity in middle life is associated with a future risk
of poorer memory in older age [15,40,41].
A high circulating glucose concentration was, some-
what surprising, associated with better semantic memory
in men. We have not found any other publication cor-
roborating this finding; thus it must be tested in other
studies to evaluate the robustness of this observation.
A major strength of the present study is the extensive
memory tests performed in population-based memory
study that were combined with the results from a
population-based health survey. The latter included
standardized oral glucose tolerance tests and question-
naires about cardiovascular events, hypertension, and
lifestyle. Another strength in this study is the use of PLS
as statistical method. PLS is able to deal with multicoli-
nearity unlike for example multiple linear regression
who assumes independence among measures. To elimin-
ate the effect of multicolinearity makes it possible to re-
main a higher statistical power by isolating the effect of
each potential influencing factor.
This study has some limitations. There was a time gap
(<6 months) between collection of data in the studies
that theoretically could allow changes in metabolic bal-
ance, but there was no apparent effect on episodic or se-
mantic memory in our results due to this difference in
time. The CES-D screening test for depression was miss-
ing in 48 (16%) participants, and it is possible that some
of those participants were suffering from depression that
might have affected memory functions. However, the ex-
clusion of participants without information on CES-D
did not alter the results.
The participants were asked about previous CVD and it
was adjusted for in the statistical analysis, but no neuroim-
aging or neurological examination was made. Considering
that 24% of the population reported previous CVD, it is
possible that some of the participants had vascular
changes that could affect the results. There was a potential
for selection bias in the study population by linkage of two
large population studies. However, when we compared
education and weight between the 1346 persons in the
first sample and the 291 persons in the study sample there
was no significant difference. This is a cross-sectional
study and, therefore, we are not able to study any direction
of the effect of glucose on memory function. There was afairly wide distribution of fasting plasma insulin in women.
This may have led to false negative results. However, since
the effect size of plasma insulin was so small it is not rea-
sonable to assume that it has any relevant effect. Finally,
HOMA-IR was used as a proxy for insulin resistance. A
study using the gold standard, i.e., the hyperinsulinemic
euglycemic clamp technique to further evaluate the effect
of insulin and glucose on cognitive function would be of
major interest. However, clamp techniques are not feasible
in large epidemiological studies.
Over the past several decades, there has been a world-
wide increase in diseases related to metabolic perturba-
tions such as obesity, diabetes, and hypertension [42].
With a growing number of older persons, the impact of
these conditions will have an increasingly significant role
in health care. Metabolic changes are unlike many other
risk factors for dementia and memory impairment be-
cause they are preventable with lifestyle changes or drug
treatments. Thus, our study focuses on the association
between early stages of metabolic perturbations and
memory dysfunction because the early stages represent a
window of opportunity for preventive measures.
Conclusions
In conclusion, we found no significant association between
fasting insulin concentrations or insulin resistance and epi-
sodic or semantic memory. We found a negative associ-
ation between fasting glucose concentration and episodic
memory in women. This suggests that elevated glucose
concentrations could be important as a modifier of episodic
memory in a middle-aged non-diabetic population. This is
likely to be through interactions with other metabolic and
age-related processes that are already in progress.
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